We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$451M
AUM Growth
-$16.1M
Cap. Flow
-$29.1M
Cap. Flow %
-6.45%
Top 10 Hldgs %
36.92%
Holding
175
New
4
Increased
16
Reduced
46
Closed
15

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$13M
2
APTV icon
Aptiv
APTV
+$8.34M
3
JPM icon
JPMorgan Chase
JPM
+$3.81M
4
ALKS icon
Alkermes
ALKS
+$2.41M
5
V icon
Visa
V
+$2.03M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.7M
2
SWN
Southwestern Energy Company
SWN
+$10.7M
3
APA icon
APA Corp
APA
+$10.6M
4
AGN
Allergan plc
AGN
+$7.65M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.27M

Sector Composition

Rank Sector Weight
1 Financials 23.48%
2 Technology 17.62%
3 Healthcare 14.5%
4 Energy 9.7%
5 Consumer Staples 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
26
Aptiv
APTV
$10.3B
$8.36M 1.85%
+124,175
New +$8.34M
MDLZ icon
27
Mondelez International
MDLZ
$78.5B
$8.33M 1.85%
187,885
– –
AFL icon
28
Aflac
AFL
$61.2B
$7.04M 1.56%
202,370
-798
-0.4% -$28.1K
ENOV icon
29
Enovis
ENOV
$1.4B
$6.87M 1.52%
111,087
+4,183
+4% +$247K
ETN icon
30
Eaton
ETN
$173B
$5.26M 1.17%
78,430
– –
JPM icon
31
JPMorgan Chase
JPM
$956B
$5.22M 1.16%
60,550
+50,000
+474% +$3.81M
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.35T
$5.17M 1.15%
134,020
– –
CSCO icon
33
Cisco
CSCO
$483B
$4.47M 0.99%
148,096
-325
-0.2% -$9.91K
AMAT icon
34
Applied Materials
AMAT
$415B
$4.33M 0.96%
134,120
– –
CERN
35
DELISTED
Cerner Corp
CERN
$3.95M 0.88%
83,315
-74,726
-47% -$3.97M
PG icon
36
Procter & Gamble
PG
$340B
$3.52M 0.78%
41,907
-419
-1% -$35.7K
GILD icon
37
Gilead Sciences
GILD
$165B
$2.83M 0.63%
39,450
– –
MMM icon
38
3M
MMM
$93.9B
$2.51M 0.56%
16,794
– –
ALKS icon
39
Alkermes
ALKS
$8.29B
$2.5M 0.55%
+45,000
New +$2.41M
FLS icon
40
Flowserve
FLS
$10.1B
$2.21M 0.49%
46,000
+6,900
+18% +$320K
AGN
41
DELISTED
Allergan plc
AGN
$1.88M 0.42%
8,974
-36,925
-80% -$7.65M
XOM icon
42
ExxonMobil
XOM
$662B
$1.78M 0.39%
19,718
-1,192
-6% -$104K
ABBV icon
43
AbbVie
ABBV
$438B
$1.69M 0.38%
27,045
+200
+0.7% +$12.2K
APA icon
44
APA Corp
APA
$14.4B
$1.69M 0.37%
26,611
-168,809
-86% -$10.6M
VRTX icon
45
Vertex Pharmaceuticals
VRTX
$133B
$1.55M 0.34%
21,085
-77,080
-79% -$6.27M
RDS.A
46
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.5M 0.33%
28,549
– –
ALB icon
47
Albemarle
ALB
$15.5B
$1.24M 0.27%
14,358
-675
-4% -$57.1K
CYS.PRB
48
DELISTED
CYS Investments, Inc.
CYS.PRB
$964K 0.21%
42,450
+9,600
+29% +$225K
ROST icon
49
Ross Stores
ROST
$81.7B
$938K 0.21%
14,300
– –
T icon
50
AT&T
T
$165B
$866K 0.19%
26,984
– –
1
2
3 4 5

Similar funds

NC
Naman Capital Sao Paulo, Brazil $360M AUM 27.43% 1-Year Est. Return
RIP
Rhino Investment Partners West Conshohocken, Pennsylvania $359M AUM 22.33% 1-Year Est. Return
LSC
Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NI
NFC Investments Memphis, Tennessee $359M AUM 11.31% 1-Year Est. Return
RA
RR Advisors Dallas, Texas $360M AUM 28.52% 1-Year Est. Return
SWM
SK Wealth Management Providence, Rhode Island $360M AUM 14.81% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 8.03% 1-Year Est. Return

Kelly Lawrence W & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Kelly Lawrence W & Associates held 175 positions worth $451M, down 3.4% from $467M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Kelly Lawrence W & Associates withdrew a net $29.1M in Q4 2016, closing 15 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Kelly Lawrence W & Associates opened a new position in Aptiv worth $8.36M.

  • Kelly Lawrence W & Associates's largest Q4 2016 buy was Aptiv: 124,175 shares worth $8.36M.
  • Kelly Lawrence W & Associates added most to Merck in Q4 2016, an estimated $13M increase.
  • Kelly Lawrence W & Associates's biggest Q4 2016 reduction was APA Corp, cutting an estimated $10.6M.
  • Kelly Lawrence W & Associates fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $10.7M.
  • Kelly Lawrence W & Associates's ten largest holdings make up 37% of its $451M portfolio in Q4 2016.
  • Kelly Lawrence W & Associates opened 4 new positions and closed 15 in Q4 2016.
  • Kelly Lawrence W & Associates's portfolio value fell 3.4% quarter-over-quarter to $451M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.